Related by context. Frequent words. (Click for all words.) 71 blinded placebo controlled 66 single ascending dose 64 dose escalation trial 64 double blinded placebo 63 multicenter randomized double 62 multiple ascending dose 62 blind placebo controlled 61 dose escalation study 61 randomized placebo controlled 61 primary hypercholesterolemia 61 blind randomized placebo 61 multicentre 61 Engerix B 61 Phase III randomized 60 placebo controlled Phase 60 placebo controlled 60 label dose escalation 60 blind randomized 60 relapsed refractory multiple myeloma 60 #mg/day [001] 60 multicenter randomized 60 Phase Ia 60 prospective observational 59 ascending doses 59 phase IIa 59 label multicenter 59 Phase 2a trial 59 Phase III Clinical Trial 59 Clinical Study 59 double blind placebo 59 randomized double 59 active comparator 59 pharmacokinetic PK 59 PREZISTA r 59 Presents Positive 59 Adalimumab 58 Pivotal Phase III 58 Chronic Heart Failure 58 pharmacokinetics PK 58 placebo controlled clinical 58 Phase 1b trial 58 Phase 1b clinical 58 Completes Enrollment 58 Chronic Idiopathic Constipation 58 peripheral neuropathic pain 58 placebo controlled randomized 58 TYGACIL 58 plus methotrexate 58 forodesine 58 Pivotal Trial 58 safety tolerability pharmacokinetics 58 diabetic neuropathic pain 58 pharmacodynamics 57 randomized Phase III 57 Pegasys ® 57 Amrubicin 57 Phase Ib 57 patients undergoing percutaneous 57 multicenter 57 IIa trial 57 Phase 2a clinical 57 Chronic Hepatitis C 57 phase IIb clinical 57 randomized 57 multicenter Phase 56 blind randomized controlled 56 retrospective cohort study 56 Phenoptin 56 prospective cohort 56 Researchers randomly assigned 56 pulmonology portfolio 56 Diamyd ® 56 Diabetic Macular Edema 56 randomized controlled 56 RRMS patients 56 Phase Ib clinical 56 pitavastatin 56 IIa clinical trial 56 nondiabetic 56 placebo controlled studies 56 multicenter study 56 Phase IIa trial 55 Navelbine 55 Phase 1b 55 Pivotal Phase 55 PRECiSE 55 6R BH4 55 multicenter clinical 55 diabetic peripheral neuropathic pain 55 randomized #:# 55 hepatitis C HCV 55 Phase IIb clinical 55 investigational oral 55 Multicenter 55 Phase III Trial 55 Metastatic Melanoma 55 prospective multicenter 55 HCV infected 55 liver transplant recipients 55 normotensive 55 eszopiclone